Latest Insider Transactions at Generation Bio Co. (GBIO)
This section provides a real-time view of insider transactions for Generation Bio Co. (GBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Generation Bio Co. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Generation Bio Co.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2021
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,267
+3.23%
|
$45,068
$4.59 P/Share
|
|
Dec 15
2020
|
Mark D. Angelino CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,301
-0.76%
|
$185,535
$35.2 P/Share
|
|
Dec 15
2020
|
Mark D. Angelino CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,301
+1.49%
|
$21,204
$4.59 P/Share
|
|
Dec 15
2020
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,151,882
-9.12%
|
-
|
|
Dec 10
2020
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,540
-1.71%
|
$389,980
$37.92 P/Share
|
|
Dec 10
2020
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,540
+4.81%
|
$0
$0.6 P/Share
|
|
Jun 16
2020
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
650,000
+28.75%
|
$12,350,000
$19.0 P/Share
|
|
Jun 16
2020
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
961,215
+50.0%
|
-
|
|
Jun 16
2020
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
800,000
+22.14%
|
$15,200,000
$19.0 P/Share
|
|
Jun 16
2020
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,014,191
+50.0%
|
-
|
|
Jun 16
2020
|
Zone Healthcare Holdings, LLC |
BUY
Open market or private purchase
|
Direct |
400,000
+17.25%
|
$7,600,000
$19.0 P/Share
|
|
Jun 16
2020
|
Zone Healthcare Holdings, LLC |
BUY
Conversion of derivative security
|
Direct |
1,518,819
+50.0%
|
-
|
|
Jun 16
2020
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
225,000
+15.94%
|
$4,275,000
$19.0 P/Share
|
|
Jun 16
2020
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
961,215
+35.58%
|
-
|